1NCV
| DETERMINATION CC-CHEMOKINE MCP-3, NMR, 7 STRUCTURES | Descriptor: | MONOCYTE CHEMOATTRACTANT PROTEIN 3 | Authors: | Meunier, S, Bernassau, J.M, Guillemot, J.C, Ferrara, P, Darbon, H. | Deposit date: | 1997-02-05 | Release date: | 1997-10-15 | Last modified: | 2022-02-23 | Method: | SOLUTION NMR | Cite: | Determination of the three-dimensional structure of CC chemokine monocyte chemoattractant protein 3 by 1H two-dimensional NMR spectroscopy. Biochemistry, 36, 1997
|
|
1O80
| |
1O7Z
| |
1NR2
| High resolution crystal structures of thymus and activation-regulated chemokine | Descriptor: | Thymus and activation-regulated chemokine | Authors: | Asojo, O.A, Boulegue, C, Hoover, D.M, Lu, W, Lubkowski, J. | Deposit date: | 2003-01-23 | Release date: | 2003-08-05 | Last modified: | 2024-04-03 | Method: | X-RAY DIFFRACTION (2.18 Å) | Cite: | Structures of thymus and activation-regulated chemokine (TARC). Acta Crystallogr.,Sect.D, 59, 2003
|
|
1O7Y
| Crystal structure of IP-10 M-form | Descriptor: | SMALL INDUCIBLE CYTOKINE B10, SULFATE ION | Authors: | Swaminathan, G.J, Holloway, D.E, Papageorgiou, A.C, Acharya, K.R. | Deposit date: | 2002-11-20 | Release date: | 2003-05-08 | Last modified: | 2023-12-13 | Method: | X-RAY DIFFRACTION (3 Å) | Cite: | Crystal Structures of Oligomeric Forms of the Ip-10/Cxcl10 Chemokine Structure, 11, 2003
|
|
1NR4
| High resolution crystal structures of thymus and activation-regulated chemokine | Descriptor: | SULFATE ION, Thymus and activation-regulated chemokine | Authors: | Asojo, O.A, Boulegue, C, Hoover, D.M, Lu, W, Lubkowski, J. | Deposit date: | 2003-01-23 | Release date: | 2003-08-05 | Last modified: | 2024-04-03 | Method: | X-RAY DIFFRACTION (1.72 Å) | Cite: | Structures of thymus and activation-regulated chemokine (TARC). Acta Crystallogr.,Sect.D, 59, 2003
|
|
1PFN
| PF4-M2 CHIMERIC MUTANT WITH THE FIRST 10 N-TERMINAL RESIDUES OF R-PF4 REPLACED BY THE N-TERMINAL RESIDUES OF THE IL8 SEQUENCE. MODELS 16-27 OF A 27-MODEL SET. | Descriptor: | PF4-M2 CHIMERA | Authors: | Mayo, K.H, Roongta, V, Ilyina, E, Milius, R, Barker, S, Quinlan, C, La Rosa, G, Daly, T.J. | Deposit date: | 1995-07-18 | Release date: | 1996-01-29 | Last modified: | 2021-11-03 | Method: | SOLUTION NMR | Cite: | NMR solution structure of the 32-kDa platelet factor 4 ELR-motif N-terminal chimera: a symmetric tetramer. Biochemistry, 34, 1995
|
|
1PFM
| PF4-M2 CHIMERIC MUTANT WITH THE FIRST 10 N-TERMINAL RESIDUES OF R-PF4 REPLACED BY THE N-TERMINAL RESIDUES OF THE IL8 SEQUENCE. MODELS 1-15 OF A 27-MODEL SET. | Descriptor: | PF4-M2 CHIMERA | Authors: | Mayo, K.H, Roongta, V, Ilyina, E, Milius, R, Barker, S, Quinlan, C, La Rosa, G, Daly, T.J. | Deposit date: | 1995-07-18 | Release date: | 1996-01-29 | Last modified: | 2021-11-03 | Method: | SOLUTION NMR | Cite: | NMR solution structure of the 32-kDa platelet factor 4 ELR-motif N-terminal chimera: a symmetric tetramer. Biochemistry, 34, 1995
|
|
1PLF
| |
1QE6
| INTERLEUKIN-8 WITH AN ADDED DISULFIDE BETWEEN RESIDUES 5 AND 33 (L5C/H33C) | Descriptor: | INTERLEUKIN-8 VARIANT, SULFATE ION | Authors: | Gerber, N, Lowman, H, Artis, D.R, Eigenbrot, C. | Deposit date: | 1999-07-13 | Release date: | 2000-03-22 | Last modified: | 2018-01-31 | Method: | X-RAY DIFFRACTION (2.35 Å) | Cite: | Receptor-binding conformation of the "ELR" motif of IL-8: X-ray structure of the L5C/H33C variant at 2.35 A resolution. Proteins, 38, 2000
|
|
1QNK
| TRUNCATED HUMAN GROB[5-73], NMR, 20 STRUCTURES | Descriptor: | C-X-C motif chemokine 2 | Authors: | Qian, Y.Q, Johanson, K, McDevitt, P. | Deposit date: | 1999-10-18 | Release date: | 2000-02-04 | Last modified: | 2018-06-13 | Method: | SOLUTION NMR | Cite: | Nuclear magnetic resonance solution structure of truncated human GRObeta [5-73] and its structural comparison with CXC chemokine family members GROalpha and IL-8. J. Mol. Biol., 294, 1999
|
|
1QG7
| STROMA CELL-DERIVED FACTOR-1ALPHA (SDF-1ALPHA) | Descriptor: | STROMAL CELL-DERIVED FACTOR 1 ALPHA, SULFATE ION | Authors: | Senda, T, Nandhagopal, N, Sugimoto, K, Mitsui, Y. | Deposit date: | 1999-04-21 | Release date: | 2001-02-28 | Last modified: | 2023-12-27 | Method: | X-RAY DIFFRACTION (2 Å) | Cite: | Crystal structure of recombinant native SDF-1alpha with additional mutagenesis studies: an attempt at a more comprehensive interpretation of accumulated structure-activity relationship data. J.Interferon Cytokine Res., 20, 2000
|
|
1RJT
| |
1RHP
| |
1RTO
| |
1ROD
| CHIMERIC PROTEIN OF INTERLEUKIN 8 AND HUMAN MELANOMA GROWTH STIMULATING ACTIVITY PROTEIN, NMR | Descriptor: | CHIMERIC PROTEIN OF INTERLEUKIN 8 AND HUMAN MELANOMA GROWTH STIMULATING ACTIVITY PROTEIN | Authors: | Roesch, P, Sticht, H, Auer, M, Schmitt, B, Besemer, J, Horcher, M, Kirsch, T, Lindley, I.J.D. | Deposit date: | 1995-11-24 | Release date: | 1996-06-10 | Last modified: | 2022-03-02 | Method: | SOLUTION NMR | Cite: | Structure and activity of a chimeric interleukin-8-melanoma-growth-stimulatory-activity protein. Eur.J.Biochem., 235, 1996
|
|
1RTN
| |
1SDF
| SOLUTION STRUCTURE OF STROMAL CELL-DERIVED FACTOR-1 (SDF-1), NMR, MINIMIZED AVERAGE STRUCTURE | Descriptor: | STROMAL CELL-DERIVED FACTOR-1 | Authors: | Crump, M.P, Rajarathnam, K, Clark-Lewis, I, Sykes, B.D. | Deposit date: | 1997-11-15 | Release date: | 1998-01-28 | Last modified: | 2022-03-02 | Method: | SOLUTION NMR | Cite: | Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J., 16, 1997
|
|
1U4R
| Crystal Structure of human RANTES mutant 44-AANA-47 | Descriptor: | SULFATE ION, Small inducible cytokine A5 | Authors: | Shaw, J.P, Johnson, Z, Borlat, F, Zwahlen, C, Kungl, A, Roulin, K, Harrenga, A, Wells, T.N.C, Proudfoot, A.E.I. | Deposit date: | 2004-07-26 | Release date: | 2004-11-09 | Last modified: | 2023-08-23 | Method: | X-RAY DIFFRACTION (2.2 Å) | Cite: | The X-ray structure of RANTES: heparin-derived disaccharides allows the rational design of chemokine inhibitors. Structure, 12, 2004
|
|
1U4L
| human RANTES complexed to heparin-derived disaccharide I-S | Descriptor: | 4-deoxy-2-O-sulfo-alpha-L-threo-hex-4-enopyranuronic acid-(1-4)-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranose, ACETIC ACID, Small inducible cytokine A5 | Authors: | Shaw, J.P, Johnson, Z, Borlat, F, Zwahlen, C, Kungl, A, Roulin, K, Harrenga, A, Wells, T.N.C, Proudfoot, A.E.I. | Deposit date: | 2004-07-26 | Release date: | 2004-11-09 | Last modified: | 2023-08-23 | Method: | X-RAY DIFFRACTION (2 Å) | Cite: | The X-ray structure of RANTES: heparin-derived disaccharides allows the rational design of chemokine inhibitors. Structure, 12, 2004
|
|
1U4M
| human RANTES complexed to heparin-derived disaccharide III-S | Descriptor: | 4-deoxy-2-O-sulfo-alpha-L-threo-hex-4-enopyranuronic acid-(1-4)-2-deoxy-2-(sulfoamino)-alpha-D-glucopyranose, ACETIC ACID, Small inducible cytokine A5 | Authors: | Shaw, J.P, Johnson, Z, Borlat, F, Zwahlen, C, Kungl, A, Roulin, K, Harrenga, A, Wells, T.N.C, Proudfoot, A.E.I. | Deposit date: | 2004-07-26 | Release date: | 2004-11-09 | Last modified: | 2023-08-23 | Method: | X-RAY DIFFRACTION (2 Å) | Cite: | The X-ray structure of RANTES: heparin-derived disaccharides allows the rational design of chemokine inhibitors. Structure, 12, 2004
|
|
1U4P
| Crystal Structure of human RANTES mutant K45E | Descriptor: | ACETIC ACID, Small inducible cytokine A5 | Authors: | Shaw, J.P, Johnson, Z, Borlat, F, Zwahlen, C, Kungl, A, Roulin, K, Harrenga, A, Wells, T.N.C, Proudfoot, A.E.I. | Deposit date: | 2004-07-26 | Release date: | 2004-11-09 | Last modified: | 2021-10-20 | Method: | X-RAY DIFFRACTION (1.7 Å) | Cite: | The X-ray structure of RANTES: heparin-derived disaccharides allows the rational design of chemokine inhibitors. Structure, 12, 2004
|
|
1TVX
| |
7S5A
| Crystal structure of human chemokine CCL8 | Descriptor: | C-C motif chemokine 8 | Authors: | Bhusal, R.P, Devkota, S.R, Aryal, P, Wilce, M.C.J, Stone, M.J. | Deposit date: | 2021-09-10 | Release date: | 2021-09-29 | Last modified: | 2023-10-18 | Method: | X-RAY DIFFRACTION (1.37 Å) | Cite: | Structure-guided engineering of tick evasins for targeting chemokines in inflammatory diseases. Proc.Natl.Acad.Sci.USA, 119, 2022
|
|
7STA
| |